Sanaria, malaria program to begin human trials of novel vaccine

04/23/2009 | American City Business Journals

Biotech firm Sanaria and the Path Malaria Vaccine Initiative are preparing to launch the first human trials of a vaccine that contains a weakened version of an entire malaria parasite found in radiation-zapped mosquitoes. The groups plan to enroll 104 healthy volunteers and expect to treat the first patient in mid-May.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN